Co-Diagnostics, Inc. (NASDAQ:CODX) CEO Dwight Egan tells Proactive the Salt Lake City, Utah-based company will begin selling its new diagnostic test called the Vector Smart NAM-e multiplex test, which detects the eastern equine encephalitis virus (EEE), with West Nile virus, and St. Louis encephalitis. Egan says EEE is a mosquito-borne disease that kills half of those who are infected. The company is selling the diagnostic to counties within the US that would use it to test mosquito populations.
Full interview: Co-Diagnostics begins selling newest product that detects the eastern equine encephalitis virus
Quick facts: Co-Diagnostics
Price: 3.05 USD
Market Cap: $75.99 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Co-Diagnostics named herein, including the promotion by the Company of Co-Diagnostics in any Content on the Site, the Company receives from...FOR OUR FULL DISCLAIMER CLICK HERE